Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI-1-positive, 3q21q26 syndrome and T cell-line antigen expression: what is the EVI-1 gene role?

Br J Haematol. 2002 Aug;118(2):438-41. doi: 10.1046/j.1365-2141.2002.03727.x.

Abstract

Two cases of acute myeloid leukaemia (AML) with CD2 and CD7 expression associated with diabetes insipidus (DI) as the initial symptom are presented. Both patients had t(3;3)(q21;q26) associated with monosomy 7 and EVI-1 overexpression. No neurohypophysis infiltration was evident. One patient died during induction chemotherapy, the other did not respond to therapy and died with persistent DI. Our findings further support the existence of a distinct AML entity characterized by the presence of DI, abnormalities of chromosome 3q, dysmegakaryopoiesis and poor outcome, and provide evidence of EVI-1 gene involvement. The possible role of chromosome 3q26 abnormalities in determining this peculiar clinical-biological association is emphasized.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Antigens, CD7 / metabolism
  • CD2 Antigens / metabolism
  • Chromosomes, Human, Pair 3 / genetics*
  • Chromosomes, Human, Pair 7 / genetics
  • DNA-Binding Proteins / genetics*
  • Diabetes Insipidus / etiology*
  • Fatal Outcome
  • Female
  • Gene Expression
  • Humans
  • Leukemia, Myeloid / genetics*
  • MDS1 and EVI1 Complex Locus Protein
  • Male
  • Monosomy
  • Proto-Oncogenes*
  • Syndrome
  • Transcription Factors*
  • Translocation, Genetic / genetics

Substances

  • Antigens, CD7
  • CD2 Antigens
  • DNA-Binding Proteins
  • MDS1 and EVI1 Complex Locus Protein
  • MECOM protein, human
  • Transcription Factors